The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells
- PMID: 18981100
- DOI: 10.4049/jimmunol.181.10.6820
The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells
Abstract
We have examined how the host environment influences the graft-vs-leukemia (GVL) response following transfer of donor T cells to allogeneic chimeras. Donor T cells induce significant GVL when administered in large numbers to established mixed chimeras (MC). However, when using limiting numbers of T cells, we found that late transfer to MC induced less GVL than did early transfer to freshly irradiated allogeneic recipients. Late donor T cell transfer to MC was associated with marked accumulation of anti-host CD8 cells within the spleen, but delayed kinetics of differentiation, reduced expression of effector molecules including IFN-gamma, impaired cytotoxicity, and higher rates of sustained apoptosis. Furthermore, in contrast to the spleen, we observed a significant delay in donor CD8 cell recruitment to the bone marrow, a key location for hematopoietic tumors. Increasing the numbers of T cells transferred to MC led to the enhancement of CTL activity and detectable increases in absolute numbers of IFN-gamma(+) cells without inducing graft-vs-host disease (GVHD). TLR-induced systemic inflammation accelerated differentiation of functional CTL in MC but was associated with severe GVHD. In the absence of inflammation, both recipient T and non-T cell populations impeded the full development of GVHD-inducing effector function. We conclude that per-cell deficits in the function of donor CD8 cells activated in MC may be overcome by transferring larger numbers of T cells without inducing GVHD.
Similar articles
-
Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.Biol Blood Marrow Transplant. 2006 Apr;12(4):397-407. doi: 10.1016/j.bbmt.2005.11.519. Biol Blood Marrow Transplant. 2006. PMID: 16545723
-
Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.Transplantation. 2003 Jul 27;76(2):297-305. doi: 10.1097/01.TP.0000072014.83469.2D. Transplantation. 2003. PMID: 12883182
-
Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.Blood. 2002 Jun 1;99(11):4207-15. doi: 10.1182/blood.v99.11.4207. Blood. 2002. PMID: 12010827
-
Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.Leuk Lymphoma. 2000 Jul;38(3-4):221-34. doi: 10.3109/10428190009087014. Leuk Lymphoma. 2000. PMID: 10830730 Review.
-
The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.Leuk Lymphoma. 1999 May;33(5-6):409-20. doi: 10.3109/10428199909058446. Leuk Lymphoma. 1999. PMID: 10342569 Review.
Cited by
-
Complete response of myeloid sarcoma with cardiac involvement to radiotherapy.J Thorac Dis. 2016 Jun;8(6):1323-8. doi: 10.21037/jtd.2016.04.47. J Thorac Dis. 2016. PMID: 27293853 Free PMC article.
-
CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.J Immunol. 2015 Feb 1;194(3):1080-9. doi: 10.4049/jimmunol.1401703. Epub 2014 Dec 24. J Immunol. 2015. PMID: 25539815 Free PMC article.
-
Emerging concepts in haematopoietic cell transplantation.Nat Rev Immunol. 2012 May 25;12(6):403-16. doi: 10.1038/nri3226. Nat Rev Immunol. 2012. PMID: 22627859 Free PMC article. Review.
-
Transplantation tolerance in nonhuman primates and humans.Bone Marrow Transplant. 2019 Aug;54(Suppl 2):815-821. doi: 10.1038/s41409-019-0620-3. Bone Marrow Transplant. 2019. PMID: 31431694 Free PMC article. Review.
-
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells.Blood. 2011 Jan 20;117(3):1030-41. doi: 10.1182/blood-2010-04-283119. Epub 2010 Nov 9. Blood. 2011. PMID: 21063028 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials